Your browser doesn't support javascript.
loading
Effect of oral phosphate and alendronate on bone mineral density when given as adjunctive therapy to growth hormone replacement in adult growth hormone deficiency.
White, H D; Ahmad, A M; Durham, B H; Joshi, A A; Fraser, W D; Vora, J P.
Affiliation
  • White HD; Department of Diabetes and Endocrinology, Royal Liverpool University Hospital, Liverpool L7 8XP, United Kingdom. h.white@ukf.net
J Clin Endocrinol Metab ; 96(3): 726-36, 2011 Mar.
Article in En | MEDLINE | ID: mdl-21252245
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phosphates / Bone Density / Alendronate / Human Growth Hormone / Bone Density Conservation Agents Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 2011 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phosphates / Bone Density / Alendronate / Human Growth Hormone / Bone Density Conservation Agents Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 2011 Document type: Article Affiliation country: Country of publication: